No photo available


Do not miss out on this spectacular opportunity. This Pharmaceutical company is fully compliant with manufacturing standards and is licensed to fill prescription medicines from all over the United States.

Already cash flow positive the company is now in the process of a merger with a USA public company.

The physical manufacturing facility is a 30,000 sq ft building and can produce almost any pharmaceutical product or medicine. In addition to this capability the team of researchers and doctors also have three patents. One if an alternative Fentanyl treatment which is already approved by the FDA and is a potential answer to the $750 million a year Febtanyl treatment market. The second if an opioid treatment, also FDA approved and the third is a unique cancer (bowel and colon) treatment which has just been introduced into the marketplace.

This is a young, aggressive pharmaceutical company with a great pipeline of future potential products.

The Limited Partnership units are $25,000 USD each and can be secured with as little as $5,000 USD down OAC.

Investors will also have the opinion of converting their LP units into stock of the public company for even more appreciation.

Learn More

Sign up for a free membership. Get instant access to thousands of listings. Learn about our membership plans.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.